Civil Liberties, Economic Slowdown, and Public Health during the time of Pandemic: A Cross-Country Randomized Trial
Last registered on March 31, 2020

Pre-Trial

Trial Information
General Information
Title
Civil Liberties, Economic Slowdown, and Public Health during the time of Pandemic: A Cross-Country Randomized Trial
RCT ID
AEARCTR-0005609
Initial registration date
March 29, 2020
Last updated
March 31, 2020 3:15 PM EDT
Location(s)

This section is unavailable to the public. Use the button below to request access to this information.

Request Information
Primary Investigator
Affiliation
Harvard Kennedy School
Other Primary Investigator(s)
PI Affiliation
Stanford
PI Affiliation
Stanford
PI Affiliation
Harvard
PI Affiliation
MIT
Additional Trial Information
Status
In development
Start date
2020-03-29
End date
2021-03-29
Secondary IDs
Abstract
During this time of pandemic, we seek to understand how citizens view a set of fundamental tradeoffs between civil liberties, economic wellbeing and health. We have devised a novel survey instrument that seeks to capture these trade-offs explicitly. In addition to leveraging quasi-experimental variation from the severity of crisis to identify the relevant trade-offs, we will also experimentally manipulate the salience of health or civil liberties through two information treatments.
External Link(s)
Registration Citation
Citation
Alsan, Marcella et al. 2020. "Civil Liberties, Economic Slowdown, and Public Health during the time of Pandemic: A Cross-Country Randomized Trial." AEA RCT Registry. March 31. https://doi.org/10.1257/rct.5609-1.0.
Experimental Details
Interventions
Intervention(s)
Intervention Start Date
2020-03-29
Intervention End Date
2021-03-29
Primary Outcomes
Primary Outcomes (end points)
The tradeoff between health and civil liberties as well as health and economic wellbeing.
Primary Outcomes (explanation)
Willigness to pay (in terms of lived saved from COVID-19 infection) for specific liberties and economic security.


Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
Randomized trial at the individual level to three treatment arms (control, civil liberties or public health).
Experimental Design Details
Not available
Randomization Method
Randomization done in-form within country.
Randomization Unit
Individual
Was the treatment clustered?
No
Experiment Characteristics
Sample size: planned number of clusters
N/A
Sample size: planned number of observations
8,000
Sample size (or number of clusters) by treatment arms
one-third in each group
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
Harvard University
IRB Approval Date
2020-03-24
IRB Approval Number
20-0495